Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 397,039 | 382,421 | 381,267 | 380,846 | 398,022 |
| Cost of Goods | 170,546 | 164,076 | 174,241 | 147,975 | 147,937 |
| Gross Profit | 226,493 | 218,345 | 207,026 | 232,871 | 250,085 |
| Operating Expenses | 190,992 | 191,828 | 194,763 | 197,464 | 183,182 |
| Operating Income | 36,047 | 26,593 | 12,504 | 36,382 | 67,840 |
| Interest Expense | 13,751 | 13,062 | 12,464 | 12,100 | 12,894 |
| Other Income | 6,562 | 5,078 | 3,784 | 5,496 | 9,262 |
| Pre-tax Income | 28,858 | 18,609 | 3,824 | 29,778 | 64,208 |
| Income Tax | 9,024 | -888 | -360 | 5,552 | 11,262 |
| Net Income Continuous | 19,834 | 19,497 | 4,184 | 24,226 | 52,946 |
| Net Income | $19,834 | $19,497 | $4,184 | $24,226 | $52,946 |
| EPS Basic Total Ops | 0.26 | 0.24 | 0.05 | 0.30 | 0.65 |
| EPS Basic Continuous Ops | 0.25 | 0.24 | 0.05 | 0.30 | 0.64 |
| EPS Diluted Total Ops | 0.26 | 0.24 | 0.05 | 0.29 | 0.63 |
| EPS Diluted Continuous Ops | 0.25 | 0.24 | 0.05 | 0.29 | 0.64 |
| EBITDA(a) | $68,465 | $58,568 | $44,754 | $69,415 | $99,039 |